Skip to main content
Top
Published in: Current HIV/AIDS Reports 2/2018

01-04-2018 | The Global Epidemic (SH Vermund, Section Editor)

Network-Based Research on Rural Opioid Use: an Overview of Methods and Lessons Learned

Authors: April M. Young, Abby E. Rudolph, Jennifer R. Havens

Published in: Current HIV/AIDS Reports | Issue 2/2018

Login to get access

Abstract

Purpose of Review

The purpose of this paper is to provide a thorough overview of methods used for recruitment, network data collection, and network data management in a network-based study of rural people who use drugs (PWUD) and to offer methodological recommendations for future research on rural drug use.

Recent Findings

The Social Networks among Appalachian People (SNAP) study recruited a cohort of 503 rural PWUD via respondent-driven sampling (RDS) and has retained more than 80% of eligible participants over 7–9 years. SNAP has yielded important methodological insights, including that (1) RDS referral was non-random and disproportionately involved kin and (2) interviewer-administered questionnaires were successful in eliciting accurate name and age information about network members.

Summary

The SNAP experience suggests that RDS was a successful recruitment strategy for rural PWUD and questionnaires administered by community-based interviewers in the context of a Certificate of Confidentiality could elicit detailed data on PWUD risk networks.
Literature
2.
go back to reference Zibbell JE, Iqbal K, Patel RC, Suryaprasad A, Sanders KJ, Moore-Moravian L, et al. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤ 30 years-Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. MMWR Morb Mortal Wkly Rep. 2015;64(17):453–8.PubMedPubMedCentral Zibbell JE, Iqbal K, Patel RC, Suryaprasad A, Sanders KJ, Moore-Moravian L, et al. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤ 30 years-Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. MMWR Morb Mortal Wkly Rep. 2015;64(17):453–8.PubMedPubMedCentral
3.
go back to reference Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613–20.CrossRefPubMed Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613–20.CrossRefPubMed
4.
go back to reference Suryaprasad AG, White JZ, Xu F, Eichler B-A, Hamilton J, Patel A, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clin Infect Dis. 2014;59(10):1411–9.CrossRefPubMed Suryaprasad AG, White JZ, Xu F, Eichler B-A, Hamilton J, Patel A, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clin Infect Dis. 2014;59(10):1411–9.CrossRefPubMed
5.
go back to reference PDA I, Cecil G. Sheps Center for Health Services Research, Appalachian Regional Commission. Creating a culture of health in Appalachia: disparities and bright spots. August 2017. PDA I, Cecil G. Sheps Center for Health Services Research, Appalachian Regional Commission. Creating a culture of health in Appalachia: disparities and bright spots. August 2017.
6.
go back to reference Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, et al. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr (1999). 2016;73(3):323–31.CrossRef Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, et al. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr (1999). 2016;73(3):323–31.CrossRef
7.
go back to reference Zhang Z, Infante A, Meit M, English N, Dunn M, Bowers K. An analysis of mental health and substance abuse disparities & access to treatment services in the Appalachian region. Final report Washington: Appalachian Regional Commission. 2008. Zhang Z, Infante A, Meit M, English N, Dunn M, Bowers K. An analysis of mental health and substance abuse disparities & access to treatment services in the Appalachian region. Final report Washington: Appalachian Regional Commission. 2008.
8.
go back to reference Appalachian Regional Commission. Health care costs and access disparities in Appalachia. Washington, DC 2012. Appalachian Regional Commission. Health care costs and access disparities in Appalachia. Washington, DC 2012.
9.
go back to reference Young A, Jonas A, Mullins U, Halgin DS, Havens J. Network structure and the risk for HIV transmission among rural drug users. AIDS Behav. 2013;17(7):2341–51.CrossRefPubMedPubMedCentral Young A, Jonas A, Mullins U, Halgin DS, Havens J. Network structure and the risk for HIV transmission among rural drug users. AIDS Behav. 2013;17(7):2341–51.CrossRefPubMedPubMedCentral
10.
go back to reference Young AM, Jonas AB, Havens JR. Social networks and HCV viraemia in anti-HCV-positive rural drug users. Epidemiol Infect. 2013;141(02):402–11.CrossRefPubMed Young AM, Jonas AB, Havens JR. Social networks and HCV viraemia in anti-HCV-positive rural drug users. Epidemiol Infect. 2013;141(02):402–11.CrossRefPubMed
11.
go back to reference Jonas A, Young AM, Oser CB, Leukefeld C, Havens JR. OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users. Soc Sci Med. 2012;74(10):1602–9.CrossRefPubMedPubMedCentral Jonas A, Young AM, Oser CB, Leukefeld C, Havens JR. OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users. Soc Sci Med. 2012;74(10):1602–9.CrossRefPubMedPubMedCentral
12.
go back to reference Havens J, Lofwall MR, Frost SD, Oser CB, Leukefeld CG, Crosby RA. Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health. 2013;103(1):e44–52.CrossRefPubMedPubMedCentral Havens J, Lofwall MR, Frost SD, Oser CB, Leukefeld CG, Crosby RA. Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health. 2013;103(1):e44–52.CrossRefPubMedPubMedCentral
13.
go back to reference Rudolph AE, Young AM, Havens JR. Examing the social context of injection drug use: social proximity vs. geographic proximity to others who inject drugs. Am J Epidemiol. 2017;186:970–8.CrossRefPubMed Rudolph AE, Young AM, Havens JR. Examing the social context of injection drug use: social proximity vs. geographic proximity to others who inject drugs. Am J Epidemiol. 2017;186:970–8.CrossRefPubMed
14.
go back to reference Young AM, Havens JR. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. Addiction. 2011;107:587–96.CrossRefPubMedPubMedCentral Young AM, Havens JR. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. Addiction. 2011;107:587–96.CrossRefPubMedPubMedCentral
15.
go back to reference Havens JR, Oser CB, Knudsen HK, Lofwall M, Stoops WW, Walsh SL, et al. Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend. 2011;115(1–2):107–12.CrossRefPubMed Havens JR, Oser CB, Knudsen HK, Lofwall M, Stoops WW, Walsh SL, et al. Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend. 2011;115(1–2):107–12.CrossRefPubMed
16.
go back to reference Young AM, Larian N, Havens JR. Gender differences in circumstances surrounding first injection experience of rural injection drug users in the United States. Drug Alcohol Depend. 2014;134:401–5.CrossRefPubMed Young AM, Larian N, Havens JR. Gender differences in circumstances surrounding first injection experience of rural injection drug users in the United States. Drug Alcohol Depend. 2014;134:401–5.CrossRefPubMed
17.
go back to reference Hofmeister MG, Havens JR, Young AM. Silence surrounding hepatitis C status in risk relationships among rural people who use drugs. J Prim Prev. 2017;38(5):481–94.CrossRefPubMed Hofmeister MG, Havens JR, Young AM. Silence surrounding hepatitis C status in risk relationships among rural people who use drugs. J Prim Prev. 2017;38(5):481–94.CrossRefPubMed
18.
go back to reference Young AM, Halgin DS, Havens JR. Relationship-level analysis of drug users’ anticipated changes in risk behavior following HIV vaccination. AIDS care. 2015;27(8):1000–04. Young AM, Halgin DS, Havens JR. Relationship-level analysis of drug users’ anticipated changes in risk behavior following HIV vaccination. AIDS care. 2015;27(8):1000–04.
19.
go back to reference Young AM, Halgin DS, DiClemente RJ, Sterk CE, Havens JR. Will HIV vaccination reshape HIV risk behavior networks? A social network analysis of drug users’ anticipated risk compensation. PLoS One. 2014;9(7):e101047.CrossRefPubMedPubMedCentral Young AM, Halgin DS, DiClemente RJ, Sterk CE, Havens JR. Will HIV vaccination reshape HIV risk behavior networks? A social network analysis of drug users’ anticipated risk compensation. PLoS One. 2014;9(7):e101047.CrossRefPubMedPubMedCentral
20.
go back to reference Young AM, DiClemente RJ, Halgin DS, Sterk CE, Havens JR. Drug users’ willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: a social network analysis. AIDS Behav. 2014;18(9):1753–63.CrossRefPubMedPubMedCentral Young AM, DiClemente RJ, Halgin DS, Sterk CE, Havens JR. Drug users’ willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: a social network analysis. AIDS Behav. 2014;18(9):1753–63.CrossRefPubMedPubMedCentral
21.
go back to reference Young AM, Stephens DB, Khaleel HA, Havens JR. Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment. Contemp Clin Trials. 2015;41:9–16.CrossRefPubMed Young AM, Stephens DB, Khaleel HA, Havens JR. Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment. Contemp Clin Trials. 2015;41:9–16.CrossRefPubMed
22.
go back to reference Stephens DB, Young AM, Mullins UL, Havens JR. Correlates to seroprevalent herpes simplex virus type 2 among rural Appalachian drug users. J Med Virol. 2016;88(3):512–20.CrossRefPubMed Stephens DB, Young AM, Mullins UL, Havens JR. Correlates to seroprevalent herpes simplex virus type 2 among rural Appalachian drug users. J Med Virol. 2016;88(3):512–20.CrossRefPubMed
23.
go back to reference Smith RV, Young AM, Mullins UL, Havens JR. Individual and network correlates of antisocial personality disorder among rural nonmedical prescription opioid users. J Rural Health. 2017;33(2):198–207.CrossRefPubMed Smith RV, Young AM, Mullins UL, Havens JR. Individual and network correlates of antisocial personality disorder among rural nonmedical prescription opioid users. J Rural Health. 2017;33(2):198–207.CrossRefPubMed
24.
go back to reference Rudolph AE, Young AM, Havens JR. A rural/urban comparison of privacy and confidentiality concerns associated with providing sensitive location information in epidemiologic research involving persons who use drugs. Addict Behav. 2017;74:106–11.CrossRefPubMed Rudolph AE, Young AM, Havens JR. A rural/urban comparison of privacy and confidentiality concerns associated with providing sensitive location information in epidemiologic research involving persons who use drugs. Addict Behav. 2017;74:106–11.CrossRefPubMed
25.
go back to reference Young AM, Rudolph AE, Su AE, King L, Jent S, Havens JR. Accuracy of name and age data provided about network members in a social network study of people who use drugs: implications for constructing sociometric networks. Ann Epidemiol. 2016;26(11):802–9.CrossRefPubMedPubMedCentral Young AM, Rudolph AE, Su AE, King L, Jent S, Havens JR. Accuracy of name and age data provided about network members in a social network study of people who use drugs: implications for constructing sociometric networks. Ann Epidemiol. 2016;26(11):802–9.CrossRefPubMedPubMedCentral
26.
go back to reference Young AM, Rudolph AE, Quillen D, Havens JR. Spatial, temporal and relational patterns in respondent-driven sampling: evidence from a social network study of rural drug users. J Epidemiol Community Health. 2014;68(8):792–8.CrossRefPubMedPubMedCentral Young AM, Rudolph AE, Quillen D, Havens JR. Spatial, temporal and relational patterns in respondent-driven sampling: evidence from a social network study of rural drug users. J Epidemiol Community Health. 2014;68(8):792–8.CrossRefPubMedPubMedCentral
28.
go back to reference Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005;19(Suppl 2):S67–72.CrossRefPubMed Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005;19(Suppl 2):S67–72.CrossRefPubMed
29.
go back to reference Malekinejad M, Johnston LG, Kendall C, Kerr LRFS, Rifkin MR, Rutherford GW. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008;12(Suppl 1):S105–S30.CrossRefPubMed Malekinejad M, Johnston LG, Kendall C, Kerr LRFS, Rifkin MR, Rutherford GW. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008;12(Suppl 1):S105–S30.CrossRefPubMed
30.
go back to reference Lu X. Respondent-driven sampling: theory, limitations & improvements. Stockholm: Karolinska Institutet; 2013. Lu X. Respondent-driven sampling: theory, limitations & improvements. Stockholm: Karolinska Institutet; 2013.
31.
go back to reference Wang J, Falck RS, Li L, Rahman A, Carlson RG. Respondent-driven sampling in the recruitment of illicit stimulant drug users in a rural setting: findings and technical issues. Addict Behav. 2007;32(5):924–37.CrossRefPubMed Wang J, Falck RS, Li L, Rahman A, Carlson RG. Respondent-driven sampling in the recruitment of illicit stimulant drug users in a rural setting: findings and technical issues. Addict Behav. 2007;32(5):924–37.CrossRefPubMed
32.
go back to reference Heckathorn D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRef Heckathorn D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRef
33.
go back to reference Heckathorn D. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49(1):11–34.CrossRef Heckathorn D. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49(1):11–34.CrossRef
34.
35.
go back to reference Wang J, Carlson RG, Falck RS, Siegal HA, Rahman A, Li L. Respondent-driven sampling to recruit MDMA users: a methodological assessment. Drug Alcohol Depend. 2005;78(2):147–57.CrossRefPubMed Wang J, Carlson RG, Falck RS, Siegal HA, Rahman A, Li L. Respondent-driven sampling to recruit MDMA users: a methodological assessment. Drug Alcohol Depend. 2005;78(2):147–57.CrossRefPubMed
36.
go back to reference Rudolph AE, Crawford ND, Latkin C, Heimer R, Benjamin EO, Jones KC, et al. Subpopulations of illicit drug users reached by targeted street outreach and respondent-driven sampling strategies: implications for research and public health practice. Ann Epidemiol. 2011;21(4):280–9.CrossRefPubMedPubMedCentral Rudolph AE, Crawford ND, Latkin C, Heimer R, Benjamin EO, Jones KC, et al. Subpopulations of illicit drug users reached by targeted street outreach and respondent-driven sampling strategies: implications for research and public health practice. Ann Epidemiol. 2011;21(4):280–9.CrossRefPubMedPubMedCentral
37.
go back to reference Ramirez-Valles J, Heckathorn DD, Vazquez R, Diaz RM, Campbell RT. From networks to populations: the development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS Behav. 2005;9(4):387–402.CrossRefPubMed Ramirez-Valles J, Heckathorn DD, Vazquez R, Diaz RM, Campbell RT. From networks to populations: the development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS Behav. 2005;9(4):387–402.CrossRefPubMed
38.
go back to reference McCreesh N, Johnston LG, Copas A, Sonnenberg P, Seeley J, Hayes RJ, et al. Evaluation of the role of location and distance in recruitment in respondent-driven sampling. Int J Health Geogr. 2011;10:56.CrossRefPubMedPubMedCentral McCreesh N, Johnston LG, Copas A, Sonnenberg P, Seeley J, Hayes RJ, et al. Evaluation of the role of location and distance in recruitment in respondent-driven sampling. Int J Health Geogr. 2011;10:56.CrossRefPubMedPubMedCentral
39.
go back to reference Qiu P, Yang Y, Ma X, Wu F, Yuan P, Liu Q, et al. Respondent-driven sampling to recruit in-country migrant workers in China: a methodological assessment. Scand J Public Health. 2012;40(1):92–101.CrossRefPubMed Qiu P, Yang Y, Ma X, Wu F, Yuan P, Liu Q, et al. Respondent-driven sampling to recruit in-country migrant workers in China: a methodological assessment. Scand J Public Health. 2012;40(1):92–101.CrossRefPubMed
40.
go back to reference Burt RD, Hagan H, Sabin K, Thiede H. Evaluating respondent-driven sampling in a major metropolitan area: comparing injection drug users in the 2005 Seattle area national HIV behavioral surveillance system survey with participants in the RAVEN and Kiwi studies. Ann Epidemiol. 2010;20(2):159–67.CrossRefPubMedPubMedCentral Burt RD, Hagan H, Sabin K, Thiede H. Evaluating respondent-driven sampling in a major metropolitan area: comparing injection drug users in the 2005 Seattle area national HIV behavioral surveillance system survey with participants in the RAVEN and Kiwi studies. Ann Epidemiol. 2010;20(2):159–67.CrossRefPubMedPubMedCentral
41.
go back to reference Nova Research Company. Questionnaire Development System Computer Assisted Personal Interviewing. 2017. Nova Research Company. Questionnaire Development System Computer Assisted Personal Interviewing. 2017.
42.
go back to reference Needle R, Fisher DG, Weatherby N, Chitwood D, Brown B, Cesari H, et al. Reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav. 1995;9(4):242–50.CrossRef Needle R, Fisher DG, Weatherby N, Chitwood D, Brown B, Cesari H, et al. Reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav. 1995;9(4):242–50.CrossRef
43.
go back to reference Cacciola JS, Alterman AI, McLellan AT, Lin Y-T, Lynch KG. Initial evidence for the reliability and validity of a “Lite” version of the Addiction Severity Index. Drug Alcohol Depend. 2007;87(2):297–302.CrossRefPubMed Cacciola JS, Alterman AI, McLellan AT, Lin Y-T, Lynch KG. Initial evidence for the reliability and validity of a “Lite” version of the Addiction Severity Index. Drug Alcohol Depend. 2007;87(2):297–302.CrossRefPubMed
44.
go back to reference Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.PubMed Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.PubMed
45.
go back to reference Tourangeau R, Smith TW. Asking sensitive questions: the impact of data collection mode, question format, and question context. Public opinion quarterly. 1996;60(2):275–304.CrossRef Tourangeau R, Smith TW. Asking sensitive questions: the impact of data collection mode, question format, and question context. Public opinion quarterly. 1996;60(2):275–304.CrossRef
46.
go back to reference Microsoft Excel. Fuzzy Lookup Add-In. 1.0.0.0 ed2011. Microsoft Excel. Fuzzy Lookup Add-In. 1.0.0.0 ed2011.
47.
go back to reference Hopkins C, Young AM. SPIDER: semi-automated processing of interconnected dyads using entity resolution. Cambridge: Charles River Analytics and University of Kentucky; 2017. Hopkins C, Young AM. SPIDER: semi-automated processing of interconnected dyads using entity resolution. Cambridge: Charles River Analytics and University of Kentucky; 2017.
48.
go back to reference Friedman SR, Neagius A, Jose B, Curtis R, Goldstein M, Ildefonso G, et al. Sociometric risk networks and risk for HIV infection. Am J Public Health. 1997;87(8):1289–96.CrossRefPubMedPubMedCentral Friedman SR, Neagius A, Jose B, Curtis R, Goldstein M, Ildefonso G, et al. Sociometric risk networks and risk for HIV infection. Am J Public Health. 1997;87(8):1289–96.CrossRefPubMedPubMedCentral
49.
go back to reference Weeks MR, Clair S, Borgatti SP, Radda K, Schensul JJ. Social networks of drug users in high-risk sites: finding the connections. AIDS Behav. 2002;6(2):193–206.CrossRef Weeks MR, Clair S, Borgatti SP, Radda K, Schensul JJ. Social networks of drug users in high-risk sites: finding the connections. AIDS Behav. 2002;6(2):193–206.CrossRef
Metadata
Title
Network-Based Research on Rural Opioid Use: an Overview of Methods and Lessons Learned
Authors
April M. Young
Abby E. Rudolph
Jennifer R. Havens
Publication date
01-04-2018
Publisher
Springer US
Published in
Current HIV/AIDS Reports / Issue 2/2018
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-018-0391-2

Other articles of this Issue 2/2018

Current HIV/AIDS Reports 2/2018 Go to the issue

The Science of Prevention (JD Stekler and J Baeten, Section Editors)

PrEP Stigma: Implicit and Explicit Drivers of Disparity

The Science of Prevention (JD Stekler and J Baeten, Section Editors)

Genetic Cluster Analysis for HIV Prevention

HIV Pathogenesis and Treatment (AL Landay and N Utay, Section Editors)

The Role of Integrin α4β7 in HIV Pathogenesis and Treatment

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.